Surgical Pledgets Market Report Scope & Overview:

The Surgical Pledgets Market was valued at USD 790.00 Million in 2025 and is expected to reach USD 1,388.30 Million by 2035, growing at a CAGR of 5.80% from 2026-2035.

The Surgical Pledgets Market is expected to expand owing to the increase in the number of surgeries performed in the fields of cardiology, thoracic surgery, and orthopedics due to increased population aging and availability of surgical care. Pledgets are small pieces of non-absorbable felt that is soft in nature – mostly made up of PTFE or polyester. It is placed below the suture and used to distribute tension on the tissue and avoid cut-through. Pledgets play a vital part in heart valve repair, annuloplasty, vascular anastomosis, and chest closure especially when the tissue involved is delicate and under high pressure. Surgeons have started preferring pledgeted sutures in order to avoid tear-through and hemorrhage and manufactures are providing pre-sutured products, soft felts, and sterile packings.

⮞In March 2024, Advanced Medical Solutions Group completed its agreement to acquire Peters Surgical, the French maker of sutures and pledgets, adding a cardiovascular and surgical consumables portfolio to its tissue-adhesive franchise. The transaction illustrates continued consolidation among specialty suppliers of surgical accessories.

U.S. Surgical Pledgets Market Outlook:

The U.S. Surgical Pledgets Market was valued at USD 262.86 Million in 2025 and is expected to reach USD 440.56 Million by 2035, growing at a CAGR of 5.30% from 2026-2035.

U.S. Surgical Pledgets Market is driven by the large number of cardiac, vascular, and orthopedic surgeries conducted every year due to modern hospital infrastructure and extensive insurance coverage. U.S. surgeons are used to prescribing pledgeted sutures for valve repair, aortic root surgery, and chest wall closure. Group purchasing organizations determine the suppliers for hospitals. Suppliers such as Teleflex, Becton Dickinson (Bard), Medtronic, and Medline provide an array of felt pledgets, and specialized vascular suppliers cater to pediatric patients. High FDA regulation and adoption of disposable sterile pledgets favor the premium market positioning of qualified suppliers.

⮞In April 2023, Aziyo Biologics signed an exclusive U.S. distribution agreement with LeMaitre Vascular covering its cardiovascular products, including the Tyke pledget designed for neonatal and infant surgery. The arrangement expanded access to specialized pledgets for pediatric cardiac teams across American hospitals.

By Material, PTFE Felt Leads, While Biologic Materials Grow Fastest

The PTFE felt segment dominated the Surgical Pledgets Market in 2025, as the material is chemically inert, strong, and well tolerated by cardiac and vascular tissue. The use of Teflon felt by surgeons in operations involving valves, annuloplasties, and anastomoses has been going on for many years now. Experience accumulated through the years of its application plays a key role in surgeons' continued choice for this substance. This is because the Teflon felt is not only durable but distributes suture pressure evenly and does not fray easily due to being made of non-absorbent material. There is already a variety of suppliers who manufacture this type of material available in a number of thicknesses and sizes.

Bovine pericardium and other biologic materials form the fastest-growing group, as surgeons seek softer, more biocompatible options for delicate tissue, particularly in neonatal and pediatric operations. Biologic pledgets can integrate with surrounding tissue and reduce the risk of erosion that sometimes accompanies synthetic felt. Suppliers are offering treated pericardium solutions with easier handling and enhanced sterility. Increased focus on infection resistance favors these products and their usage in surgery procedures. Even though the cost is relatively high and surgeons are not familiar with these types of products, the increasing use in congenital heart surgery and reconstruction surgeries will keep growth ahead of other synthetics in terms of growth rates. The regulatory approval route is already established for biological materials.

⮞In March 2026, the European Commission adopted an amendment to the EU Medical Device Regulation addressing clinical-evaluation requirements for specified implantable devices, explicitly including suture pledgets. The change provides a relevant regulatory development for manufacturers assessing clinical evidence requirements for pledget products.

By Shape, Round & Oval Pledgets Lead, While Strip & Custom Grow Fastest

Round and oval segment dominated the Surgical Pledgets Market in 2025, as these shapes suit the interrupted pledgeted sutures most commonly used in valve replacement and repair. The small size fits well into the annulus and cusps without hindering the blood flow, and the smooth edges reduce the irritation to the surrounding tissue. There are several diameters and thicknesses available, usually supplied in pre-sterilized packages of six to match the conventional methods used in surgery. The standard sizing makes ordering easy and there is always steady demand for valve operations. The shape of instruments needed for pledget placement has been designed to match these shapes, and the hospital benefits from stable prices for the commonly used sizes.

Strips and custom pledgets are the rapidly growing shapes due to the increased use of continuous suture lines, chest wall closure, and vascular reconstructions requiring long lengths of support. Surgeons have started using cut pledgets from larger sheets to fit the unique anatomies of patients, particularly congenital and aortic surgeries. Suppliers have started offering pre-cut strips, perforated sheets, and procedure-specific kits in response to the changing market trends. Orthopedic soft tissue repair and thoracic surgeries provide other uses for these shapes, and the flexibility of custom shapes attracts surgeons dealing with high-risk patients with delicate tissues. Trimming strips for some procedures has become a common part of group purchasing agreements.

⮞In September 2026, Australia's Therapeutic Goods Administration listed Medtronic Australasia's PTFE Polymer Oval Pledgets in its 2025–26 annual-charge exemption records, providing a current regulatory-register reference for oval cardiovascular pledgets.

By Application, Cardiovascular Surgery Leads, While Orthopedic Surgery Grows Fastest

Cardiovascular surgery dominated the Surgical Pledgets Market in 2025, as heart valve repair and replacement, annuloplasty, aortic procedures, and congenital repairs rely heavily on pledgeted sutures. Calcified or degenerated tissue does not provide enough support for suture retention; hence, surgeons place felt around such tissue to avoid any problems with leakage. Cardiovascular diseases continue to be the biggest killer in the world; therefore, there are many procedures done each day, with increasing numbers due to age-related need for heart valves treatment. Clinical guidelines and a track record of safety contribute to the use of pledgets in such cases. Another factor is pediatric cardiac departments that provide special sizes of valves for children.

Orthopedic surgery is the fastest-growing application, supported by growth in rotator cuff, tendon, and ligament repairs where soft tissue must be anchored securely. Pledgets help to evenly distribute the force on damaged or weak tendons, thus decreasing the chances for pull-through and re-tear of the suture. As there are more sportsmen, the aging population, and wider use of arthroscopy, the number of procedures is increasing. Pledget manufacturers develop smaller, lower-profile pledgets that are used with minimally invasive devices, while surgeons start using them in spine and trauma reconstruction procedures, increasing the number gradually. Constructs for tendon repair that include pledgets and high strength sutures are gaining popularity in shoulder and ankle surgeries.

⮞In May 2025, Shanghai DeltaHealth Cardiovascular Hospital opened in China as the country's first wholly foreign-owned cardiovascular specialty hospital, expanding specialist cardiovascular services and introducing an internationally oriented care model for complex heart disease.

By End User, Hospitals Lead, While Ambulatory Surgical Centers Grow Fastest

Hospitals dominated the Surgical Pledgets Market in 2025, as cardiac, thoracic, and complex orthopedic operations requiring pledgets are performed mainly in inpatient surgical suites. They maintain a large supply of pledgets along with other suture materials, the purchasing process being aided by group purchasing agreements that are in favor of proven suppliers. Hospitals that provide teaching services and large cardiac centers perform the largest number of procedures, which include complex valve and congenital heart surgeries. Easy availability of cardiopulmonary bypass, intensive care, and specialty teams make sure that hospitals continue to be the main venue for pledget-intensive procedures. There is also consistent demand for revision surgeries at hospital-based cardiac surgery programs.

Ambulatory surgical centers are the fastest-growing end user, as payers and patients favor lower-cost outpatient settings for suitable orthopedic, general, and minor vascular procedures. Advances in anesthesia, minimally invasive techniques, and recovery protocols allow more operations to move out of hospitals. These centers prefer single-use, sterile, ready-to-open pledget packs that reduce reprocessing and inventory complexity. Expanding outpatient reimbursement for musculoskeletal procedures and a growing network of physician-owned centers are expected to lift consumption of pledgets in this channel over the forecast period. Surgeon ownership of centers creates strong purchasing influence, and manufacturers are building outpatient-specific kits and sales teams to capture this expanding channel.

⮞In December 2025, the U.S. Centers for Medicare & Medicaid Services finalized its 2026 outpatient payment rule, including changes to the ambulatory surgical center covered-procedure framework. The policy provides relevant context for the evolving role of outpatient facilities in surgical care.

Regional Analysis:

North America Surgical Pledgets Market Insights

North America dominated the Surgical Pledgets Market with a share of around 38.60% in 2025 due to the high number of cardiac surgeries, advanced hospital infrastructure, and widespread reimbursement. The United States performs hundreds of thousands of cardiac and vascular surgeries each year, and its surgeons adopt new suture accessories quickly. Major players Teleflex, BD, Medtronic, and Medline operate from the region. Although the mature market moderates the growth, the region is expected to grow at a rate of around 5.20% CAGR till 2035. Device company and academic investments for clinical research continue to improve pledget technology.

Major cardiac centers such as Cleveland Clinic, Mayo Clinic, and Texas Heart Institute drive innovation in surgical technique and device design. Purchasing organizations impact the pricing process, facilitating the adoption of standardized products, whereas regulatory requirements call for strict quality documentation. Programs for pediatric and congenital cardiac patients generate a stable demand for specialized pledgets, and infection prevention programs implemented by hospitals increase the usage of sterilized single-use products. Canada makes its contribution through publicly-funded cardiac programs with standardized procurement practices within provincial health care systems. Post-market surveillance and clinical registries facilitate the demonstration of long-term outcomes to prove the efficacy of the devices to surgeons, thereby justifying premium prices in U.S. and Canadian hospital systems.

⮞In January 2025, the American Heart Association released its 2025 Heart Disease and Stroke Statistics update, compiling data on cardiovascular disease, valvular disorders, procedures, and outcomes. The report provides current clinical context for the cardiovascular surgery market in the United States.

Europe Surgical Pledgets Market Insights

In 2025, Europe was expected to have a share of approximately 27.40% in the Surgical Pledgets Market on account of its universal health care systems, aging population, and established cardiac surgeries. The largest volume of the market was generated by Germany, France, the United Kingdom, and Italy, where the regulatory system encourages the purchase of quality-certified products according to the Medical Device Regulation. There is a wide choice of pledgets offered by European companies such as B. Braun, Peters Surgical, and Aesculap. Moreover, many hospitals tend to purchase pledgets from regional suppliers. The annual growth rate is estimated to be approximately 5.00%.

Germany is the leading country in the region due to its high capacity of cardiac surgeries and production of medical devices. Nordic countries focus on minimally invasive surgeries. Tender-based procurement in several countries increases competition and encourages regional producers to provide competitive offers. Conformity requirements of the Medical Device Regulation increased costs of compliance which resulted in consolidation of smaller producers; for instance, Advanced Medical Solutions acquired Peters Surgical. Eastern European countries expand their cardiac care services resulting in additional demand. Cardiac hospitals in Spain and Italy increase the number of minimally invasive valve repairs, which leads to the increased demand for small pledgets. Central European countries receive European Union financing for hospital upgrades.

⮞In March 2026, the European Commission adopted an amendment to the Medical Device Regulation covering clinical-evaluation requirements for specified devices, including suture pledgets. The regulatory change is relevant to manufacturers supplying surgical accessories to Germany and other EU markets.

Asia-Pacific Surgical Pledgets Market Insights

The Asia-Pacific region was responsible for 24.30% of the Surgical Pledgets Market in 2025 and is the fastest-growing region with a projected CAGR of 7.10% from 2026 to 2035. The demand is driven by large populations, increased incidences of cardiovascular and rheumatic heart diseases, and hospital expansion. In the region, China accounts for the highest consumption due to the increase in cardiac surgeries and production of surgical consumables locally. The investments made by the government in tertiary hospitals and insurance coverage help in increasing access to procedures which require pledgets. Increased income levels are leading to increased access to private hospitals where advanced valve repair techniques are adopted faster, and public insurance programs in China, India, and Indonesia make it easier for patients to undergo cardiac surgeries.

India is one of the fast-growing markets with cardiac hospitals in Chennai, Bengaluru, and Delhi performing large volumes at reduced costs, in addition to medical tourism. Japan and South Korea are contributing to this market due to their advanced healthcare system and the adoption of minimally invasive cardiac surgery. There are local manufacturers competing in the market with competitively priced felt pledgets, making the prices competitive. Multinational companies are expanding their distribution channels further in the region. Countries such as Thailand, Malaysia, and Vietnam are developing cardiac programs, providing additional opportunities for suppliers. The contribution of Australia comes from its quality public hospitals and high adoption of minimally invasive repair techniques.

⮞In May 2025, Shanghai DeltaHealth Cardiovascular Hospital opened as China's first wholly foreign-owned cardiovascular specialty hospital, adding specialist capacity for complex heart disease and expanding access to internationally oriented cardiovascular care in the Yangtze River Delta.

MEA & Latin America Surgical Pledgets Market Insights

The Middle East and Africa segment is one of the smaller segments in the global Surgical Pledgets Market with Saudi Arabia and the United Arab Emirates being some of the Gulf countries driving the market through their investments in specialty cardiac facilities and medical cities. Cardiovascular surgeries are increasing due to rising incidences of obesity and diabetes. The supply of products in this region is mainly through imports and involves collaborations between international players and local distributors. Access to cardiac surgery procedures is still low in Africa, but South Africa and Morocco have been gradually making progress through investments in their public and private sectors. Countries with tourism medical hubs in the region are Turkey and the Gulf and include countries such as Egypt that draw patients for treatment from neighboring areas.

The region with stable growth in terms of the surgical pledgets market is Latin America, where demand is driven by Brazil and Mexico through their health care systems in public and private sectors. Brazil carries out many cardiovascular procedures; therefore, international manufacturers and hospitals are connected through distributors in Brazil. Although there are volatile economies and currency fluctuations, governments are developing cardiovascular disease programs. Countries in this region are Argentina, Colombia, and Chile, where there are already established cardiac surgical centers. There is also medical tourism in the region, which boosts the demand for sterile single-use surgical accessories.

⮞In February 2026, the Saudi Fund for Development signed a USD 50 million development-loan agreement to finance a cardiovascular center at Al-Nahda Hospital in Chad, including a 90-bed facility intended to strengthen specialized cardiac care and support local cardiac surgery services.

Market Dynamics:

Growth Drivers: Rising Cardiovascular Procedures and Surgical Volumes

Growth in the Surgical Pledgets Market is primarily attributed to the rising number of cardiovascular and other soft tissue surgeries worldwide. Aging populations, increasing prevalence of valve disease, and greater access to surgical care are lifting procedure counts. Pledgets reduce suture pull-through, which lowers complication rates and the likelihood of reoperation, and surgeons increasingly view them as a low-cost way to improve outcomes. Each valve repair typically uses multiple pledgets, so growth in procedure volumes translates directly into higher consumption of these accessories. Rising incidence of infective endocarditis and degenerative valve disease also increases the number of complex reconstructions that require reliable suture reinforcement in surgical practice.

Advances in surgical technique add further momentum, as minimally invasive and robotic cardiac procedures require reliable suture support in confined spaces. Growing awareness of healthcare-associated infections favors sterile, individually packaged pledgets, and hospitals are standardizing on single-use products. Expanding orthopedic and sports medicine surgeries open additional applications, while rising healthcare spending in emerging economies broadens the customer base. Together, these factors support steady growth through 2035. Government programs that expand access to cardiac surgery in countries such as India, China, and Brazil are adding procedure volumes quickly, while training initiatives teach surgeons standardized pledgeted techniques that maintain consistent consumption across newly established cardiac centers over the forecast period.

⮞In September 2026, India's AIIMS Guwahati commenced its cardiac surgery program by successfully performing two open-heart operations, including surgery on a child with a congenital heart defect. The milestone illustrates the expansion of specialist cardiac-surgery capacity beyond established metropolitan centers.

Restraints: Cost Pressure and Regulatory Complexity

Pressure on costs and complicated regulations hamper growth in the Surgical Pledgets Market. Hospitals working with limited budgets and having group purchase agreements put pressure on sellers to lower prices on what is seen as commodities. Higher prices are charged for biologic pledgets and pre-sutured pledgets, which makes adoption slower in regions that consider costs when choosing between different options. Complicated requirements for getting approvals to sell pledgets from the EMDR and U.S. FDA raise costs of compliance and make it harder for smaller manufacturers to enter the market. Growth of transcatheter valve therapy decreases number of open surgical procedures in elderly patients.

Low levels of awareness about the product in some developing countries and availability of other solutions such as sutures without buttressing or any reinforcing material limit growth in these regions. Disruptions of the supply chain of raw materials like PTFE and polyester along with problems with sterilization facilities can lead to shortages of products. Recall of products or any other problems with their quality pose a reputational risk for companies. Minor differences in the thickness and density of felt can influence surgeons' choice and thus make it harder for new players to take over positions of existing products without strong clinical data.

Opportunities: Biologic Pledgets and Minimally Invasive Surgery

Development of new pledget materials of biologic and bioabsorbable nature offers substantial growth prospects for the Surgical Pledgets Market with applications in neonatal and pediatric cardiac surgery that requires more growing tissues in integration rather than fixing in place. Treated bovine pericardium, drug-eluting felts, and antimicrobial coatings can serve as a differentiation factor for manufacturers and allow for premium pricing strategy. Partnership with cardiac centers on clinical studies and agreements for distribution such as LeMaitre and Aziyo partnership provide a way to promote products to special surgeons teams. Strategic partnerships with hospitals and universities can contribute to acceptance in clinical practice and patenting of coating and absorbable constructs will help to differentiate products permanently.

In addition, minimally invasive and robotic surgery can create growth opportunities by promoting demand for low profile pledgets to deliver through narrow ports. Fastening surgical operations with pre-loaded or pre-sutured products would be valuable for hospitals seeking efficiency. Rapid growth in Asia-Pacific and Latin America countries where cardiac surgery centers develop will create market for cheap and good quality products. Emergence of ambulatory surgical centers will broaden the potential customer base for sterilized and packaged products. In order to improve acceptance by surgeons, education programs that will show how to apply pledgets properly can be offered and pledgets bundling with sutures in kits specific for certain operations will help to increase profit per case.

⮞In May 2025, the Australian and Tasmanian governments advanced plans for the Northern Heart Centre at Launceston General Hospital, with a federal commitment of AUD 120 million for a facility featuring cardiac inpatient beds, catheterization laboratories, and diagnostic services. The investment highlights opportunities associated with expanding specialist cardiac-care infrastructure.

Surgical Pledgets Market Key Players:

• Medtronic plc

• Johnson & Johnson (Ethicon)

• Becton, Dickinson and Company (Bard)

• DeRoyal Industries, Inc.

• Boz Medical

• Golnit

Surgical Pledgets Market Report Scope: